Validated drug discovery assay overcomes previous challenges in targeting NaV1.9 ion channels for chronic pain signalling
Initial twelve-month collaboration successfully identifies hit compounds and progresses into hit-to-lead optimization phase
Novel small molecule programme aims to address major unmet medical need in neuroscience
Combination of ion channel and High Throughput Screening expertise to broaden drug discovery capability
International Consortium will use primary human dorsal root ganglion neurons for identification and testing of novel pain therapeutics
